Following a wide review of data concerning the effect of alcoholconsumption on users of analgesics, the US Food and Drug Administration has proposed an alcohol warning on all over-the-counter analgesics, including aspirin, ibuprofen and acetaminophen.
The warnings are meant to alert consumers to specific risks posed by the interaction of heavy alcohol consumption and the use of certain OTC analgesics.
Warning statements would include reference to: the risk of liver damage from products containing acetaminophen for those taking three or more alcoholic drinks a day; the risk of stomach bleeding linked to aspirin, carbaspirin calcium, choline salicylate, ibuprofen, ketoprofen, magnesium salicylate, naproxen sodium and products containing sodium salicylate; and the risk of stomach bleeding and liver damage if taking products combining acetaminophen with other analgesic ingredients.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze